Xeloda for renal cell carcinoma – pro
Capecitabine is a novel fluoropyrimidine carbamate, orally administered and selectively activated to fluorouracil by a sequential triple enzyme pathway in liver and tumor cells.Oral capecitabine may be an active drug for the treatment of advanced renal cell carcinoma and is being evaluated in first- and second-line treatment schedules as monotherapy as well as in combination with immunotherapy agents. In preclinical studies, renal cell tumors demonstrated
Read more